Profile of drug utilization in the elderly living in Porto Alegre

  • Fabiana Torres Faggiani
  • Guilherme Schroeter
  • Sandro Luz Pacheco
  • Antonio C. Araujo de Souza
  • Maria C. Werlang
  • Geraldo Attilio de Carli
  • Fernanda Bueno Morrone
Keywords: Drug Utilization, Polypharmacy, Aged, Brazil

Abstract

The elderly population is one of the most rapidly increasing populations in the world. Physiological alterations induced by the aging process make these individuals more susceptible to chronic diseases and, consequently, to increased drug utilization.

Objective: To describe the profile of drug utilization in the elderly living in Porto Alegre, RS, Brazil.

Methods: An observational and cross-sectional population-based study to investigate the characteristics of the population, sources of information and types of drugs used by the elderly was performed. Four hundred and eighty patients were recruited from data supplied by the City Hall of Porto Alegre. The elderly were interviewed individually during the period from January to May 2006 by trained interviewers. A validated pharmacotherapy questionnaire was used for data collection and data were tabulated and analyzed by the SPSS 11.5 computer program.

Results: Of the 480 patients interviewed, 13.8% did not use any medication. Cardiovascular system drugs represented the pharmacological class most used by the elderly (64.0%). When ill, 71.9% of these individuals visited the doctor, while 36.9% self-medicated. For the majority (50.2%), drugs were identified by their labels. Only 41.2% of the elderly understood medical prescriptions and 68.3% of the patients studied obtained the necessary information for the appropriate use of therapy from their doctors.

Conclusions: The present study suggests that a pharmaceutical care program for the treatment, prevention, and use of medications may provide a higher efficiency to elderly drug therapy.

Downloads

Download data is not yet available.

References

1. Garrido R, Menezes PR. [O Brasil está envelhecendo: boas e más notícias por uma perspectiva epidemiológica]. Rev Bras Psiquiatr 2002;24(1):3-6.

2. Loyola Filho AI, Uchoa E, Firmo Jde O, Lima-Costa MF. [A population-based study on use of medications by elderly Brazilians: the Bambuí Health and Aging Study (BHAS)]. Cad Saúde Pública 2005;21(2):545-53.

3. Braga TB, Pfaffenbach G, Weiss DP, Barros MB, Bergsten-Mendes G. Point prevalence of drug prescriptions for elderly and non-elderly inpatients in a teaching hospital. Sao Paulo Med J 2004;122(2):48-52.

4. Acurcio Fde A, Rozenfeld S, Ribeiro AQ, Klein CH, Moura CS, Andrade CR. [Use of medications by elderly Brazilian retirees: 1--methodology and response rates of a multicenter survey]. Cad Saude Publica 2006;22(1):87-96.

5. Romano-Lieber NS, Teixeira JJ, Farhat FC, Ribeiro E, Crozatti MT, de Oliveira GS. [A literature review on pharmacists' interventions in the use of medication by elderly patients]. Cad Saude Publica 2002;18(6):1499-507.

6. Miralles MA, Kimberlin CL. Perceived access to care and medication use among ambulatory elderly in Rio de Janeiro, Brazil. Soc Sci Med 1998;46(3):345-55.

7. Brekke M, Hunskaar S, Straand J. Self-reported drug utilization, health, and lifestyle factors among 70-74 year old community dwelling individuals in Western Norway. The Hordaland Health Study (HUSK). BMC Public Health. 2006;6:121.

8. Mosegui GB, Rozenfeld S, Veras RP, Vianna CM. [Quality assessment of drug use in the elderly]. Rev Saude Publica 1999;33(5):437-44.

9. Lyra DP Jr, Rocha CE, Abriata JP, Gimenes FR, Gonzalez MM, Pelá IR. Influence of Pharmaceutical Care intervention and communication skills on the improvement of pharmacotherapeutic outcomes with elderly Brazilian outpatients. Patient Educ Couns 2007;68(2):186-92.

10. Santi V. Processos de mudanças nas atividades do farmacêutico, pp. 33-41. Anais da I Conferência Nacional de Educação Farmacêutica; 2000; Brasília, Brasil.

11. Néri EDR, Oliveira SGM, Rodrigues JLN, Medeiros MMC, Fonteles MMF. Erros na área da saúde: culpado ou inocente? Infarma 2006; 18: 3-4.

12. Instituto Brasileiro de Geografia e Estatística (IBGE). Disponível em http://www.ibge.gov.br. Acesso em 11 abr. 2006.

13. Evans JG. Drugs and falls in later life. Lancet. 2003;361(9356):448.

14. Frankfort SV, Tulner LR, van Campen JP, Koks CH, Beijnen JH. Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic. Clin Drug Investig 2006;26(3):169-74.

15. WHO. World Health Organization. Anatomical-Therapeutic-Chemical Classification - ATC 2004. In: http://www.whocc.no/atcddd; 2004.

16. Zar J.H. Biostatistical Analysis. Fourth Edition. New Jersey: Prentice Hall; 1999. ISBN 013086398X.

17. Coelho Filho JM, Marcopito LF, Castelo A. [Medication use patterns among elderly people in urban area in Northeastern Brazil]. Rev Saude Publica 2004;38(4):557-64.

18. Cordero L, Cadavid MI, Fernández-Llimós F, Díaz C, Sanz F, Loza MI. Continuing education and community pharmacists in Galicia: a study of opinions. Pharm World Sci 2004;26(3):173-7.

19. Chen YF, Dewey ME, Avery AJ; Analysis Group of The MRCCFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 2001;26(2):129-40.

20. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002;55(8):809-17.

21. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006;54(10):1516-23.

22. Teixeira JJ, Lefèvre F. [Drug prescription from the perspective of elderly patients]. Rev Saude Publica 2001;35(2):207-13.

23. Flores LM, Mengue SS. [Drug use by the elderly in Southern Brazil]. Rev Saude Publica 2005;39(6):924-9.

24. Ali Raza J, Movahed A. Use of cardiovascular medications in the elderly. Int J Cardiol 2002;85(2-3):203-15.

25. Firmo JO, Lima-Costa MF, Uchôa E. [The Bambuí Health and Aging Study (BHAS): ways of thinking and acting among hypertensive older adults]. Cad Saude Publica 2004;20(4):1029-40.

26. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21(11):1983-92.

27. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000;56(6-7):501-9.

28. Queiroz MS. [Strategies for consumption of health care by working-class families]. Cad Saude Pública 1993;9(3):272-82.

29. Zaitune MP, Barros MB, César CL, Carandina L, Goldbaum M. [Arterial hypertension in the elderly: prevalence, associated factors, and control practices in Campinas, São Paulo, Brazil]. Cad Saude Publica 2006;22(2):285-94.

30. Cosendey MA, Bermudez JA, Reis AL, Silva HF, Oliveira MA, Luiza VL. [Pharmaceutical care in primary health care: the experience of 3 Brazilian States]. Cad Saude Publica 2000;16(1):171-82.
Published
2007-11-22
Section
Original Research